Sanofi's Infilbray pill becomes first US-approved drug for rare neurological disorder
Infilbray is approved to treat type 3 Gaucher disease, the neurological variant of the disorder that causes certain fatty substances to accumulate in organs and tissues.
Reuters2 min read
Share

The logo of French drugmaker Sanofi is seen in Paris. (Reuters)
Add Emirates 24|7 to your Google News
Text Size:
